Discussing Deals in Interviews: Connecting Valuation Concepts

Introduction

"Tell me about a deal you found interesting" is one of the most common non-formula questions in investment banking interviews. It appears routine but it is genuinely revealing: a candidate who has only read headlines will give a generic answer, while a candidate who has thought through the valuation logic will demonstrate exactly the analytical instinct banks want.

The question is not asking for news commentary. It is asking whether you can apply the concepts covered across this guide to a real situation. That means you need to know the implied multiple, the premium paid, the buyer's rationale, and what the deal tells you about current market conditions.

The first filter is basic market awareness: do you follow deals in the sectors relevant to this bank and this group? Discussing a healthcare deal at a healthcare group signals genuine interest; discussing the same deal at a tech group signals poor research.

The second filter is analytical depth. Anyone can say "Alphabet acquired Wiz for $32 billion because it wanted to strengthen cloud security." Fewer candidates can then say: "That implies roughly 25-30x NTM revenue for a high-growth cybersecurity business, which is consistent with precedent transactions in the space. It made sense from Alphabet's perspective because the alternative was slower organic build-out at a time when Microsoft was pulling ahead on enterprise security integration."

The third filter is judgment. Can you form a view? Is the price fair? What could go wrong? Interviewers are not looking for certainty; they are looking for reasoned opinion.

Structure your answer in four beats, each 2-4 sentences:

Beat 1: What the deal was. State the acquirer, target, size, and deal type (all-cash, stock, mixed) in one sentence. Do not spend more than 15 seconds here. The interviewer already knows the deal.

Beat 2: Valuation. State the key implied multiple and how it compares to peer transactions or trading multiples. "The $21 billion acquisition of Exact Sciences by Abbott implies approximately 9x NTM revenue, a significant premium to the 6-7x at which comparable diagnostics businesses were trading. The premium reflects the recurring revenue stream from Cologuard and the growth trajectory Abbott is underwriting."

Beat 3: Strategic rationale. Connect the price to the synergies or strategic positioning that justified it. This is where you show understanding of acquisition premiums and synergies.

Beat 4: Your view. One or two sentences of reasoned opinion. Agree, disagree, or identify a risk. This is the differentiator.

For each deal, you should be able to identify which valuation methodology was most relevant to the transaction, and why:

Strategic tech acquisitions (SaaS, cybersecurity, AI) are most often valued on revenue multiples, particularly EV/NTM Revenue or EV/ARR, because many targets are pre-profit or have EBITDA margins temporarily compressed due to growth investment. The relevant framework is in technology and SaaS valuation.

Healthcare and pharma deals often blend revenue multiples for established businesses with probability-weighted DCF (risk-adjusted NPV) for pipeline assets. See healthcare valuation methodology.

Financial sponsor acquisitions (LBO-driven) are valued on the entry EBITDA multiple relative to the capital structure and the projected exit. Understanding the deal requires knowing whether the leverage ratio was achievable, what return threshold the sponsor was targeting, and whether the exit multiple assumption is realistic.

Industrial and consumer deals generally use EV/EBITDA against precedent transactions and trading comps, with attention to normalization if the target had one-time charges or cyclical distortions.

Target two or three deals at most, selected by these criteria:

Sector relevance. Match deals to the group. A tech group expects you to know tech deals; a healthcare group expects healthcare; a generalist group is more flexible, but leaning toward the sector you claim interest in shows genuine engagement.

Recency. Within the past 12-18 months. A deal from 2022 reads as stale research unless you are asked about a landmark transaction for a specific historical reason.

Complexity. Deals with interesting valuation or strategic angles generate better discussions than straightforward bolt-on acquisitions. Look for: cross-border deals with premium effects, deals where the price surprised the market, contested bidding processes, or transactions with significant synergy complexity.

Deal Preparation Sheet

A one-page summary prepared for each deal you plan to discuss in interviews. For each deal, document: acquirer, target, transaction value, form of consideration (cash/stock/mixed), implied EV/EBITDA or sector-appropriate multiple, premium to undisturbed price, key synergies (with dollar estimate if disclosed), strategic rationale in one sentence, and your personal view (is the price justified?). Having this information memorized allows you to answer the four-beat framework fluently and handle follow-ups without hesitation. Prepare 2-3 deal sheets tailored to the specific bank and group you are interviewing with.

Your genuine interest. Interviewers can hear enthusiasm, or the lack of it. Pick a deal that actually made you curious about something. The best deal discussions are conversations, not recitations.

Before you walk into an interview, stress-test each deal discussion by answering these questions out loud:

"What was the implied multiple and how does it compare to comps?" If you cannot answer this within five seconds, you need more preparation. The multiple is the anchor of every valuation discussion.

"What synergies justified the premium?" Quantify them if possible. "Analysts estimated roughly $300 million in annual cost synergies, primarily from shared corporate functions and procurement, phased over three years. At a 15x multiple, that implies a synergy present value of roughly $3 billion, or about 15% of the deal price." This kind of specificity separates polished candidates from average ones.

"What was the financing structure?" For a PE deal, know the leverage multiple and the debt type. For a strategic deal, know whether it was cash, stock, or mixed, and if stock, whether it was accretive or dilutive. Accretion/dilution analysis and consideration type are testable in follow-ups.

"What has happened since announcement?" If the deal has closed, did integration proceed smoothly? Did synergies materialize? If a deal was announced but not yet closed, is there regulatory risk? Knowing the deal's evolution shows that your research goes beyond the press release.

Undisturbed Price

The undisturbed share price is the target's stock price before any acquisition rumors emerged, used to calculate the true acquisition premium. A deal priced at $50 per share when the stock was trading at $35 before rumor leaks represents a 43% premium to undisturbed price. Use undisturbed price, not the price on announcement day (which may already reflect rumor), when calculating the control premium.

The best deal discussions end with a question back to the interviewer: "I'm curious what your team's view was on the synergy case, given how compressed the timeline is for integrating a business of that complexity." This signals intellectual engagement, not just preparation.

It also creates an opening for the interviewer to share their actual experience with the deal, which is the foundation of a genuine conversation rather than an assessment session. Interviews that feel like conversations tend to go better. That starts with you showing enough analytical depth to say something interesting, not just something correct.

Connect every factual claim to a valuation concept from this guide. The deal discussion is a vehicle for demonstrating that you can apply the full toolkit, from trading comps to synergy quantification to premium analysis, to a real transaction under pressure.